Part 1: Patholgoy and Classification of tumors of the nervous system -- Ethiologica and epidemiological aspects -- Imaging -- Tumor biology -- Concepts of personalized medicine in neurooncology -- Local therapies -- Part 2: Tumors of the skull -- Meningeomas and meningeal tumors -- Astrocytoma and Oligodendroglioma -- Glioblastoma -- Ependymoma and ventricular tumors -- Medulloblastoma -- Pituitary Adenomas -- Tumors of the pineal region -- Tumors of the cranial nerves -- Hemangioblastoma and von Hippel Lindau disease -- tumors of the skull base -- Orbital tumors -- Primary CNS Lymphoma -- Brain metastases and meningeomatosis -- Part 3: Neurocutaneous syndromes -- Brainstem Gliomas -- Supratentorial lobar gliomas. Thalamic gliomas -- Optic pathway gliomas -- Ganglioglioma -- Cerebellar Astrocytoma -- Rare Childhood tumors -- Ependymoma -- Medulloblastoma -- Dysembryoplastic neuroepithelial tumor -- Craniopharyngioma -- Germ cell tumors -- Choroid plexus tumours -- ATRT -- Part 4: Intramedullary tumors -- Intradural extramedullary tumors -- Epidural tumors and metastatses -- Spinal radiosurgery -- Part 5: Peripheral nerve tumors -- Part 6: Aspects of general care in neurooncology -- Epilepsy and anticonvulsant therapy -- Hydrocephalus -- Pregnancy and birth control -- Late treatment sequelae -- Quality of life -- Palliativ Care. .

The new edition has been completely revised to reflect the continually evolving landscape of neuro-oncology and provide readers with a thorough update that will inform their clinical practice. Since the previous edition, molecular neuropathology has progressed considerably, leading to a new understanding of specific clinical entities with corresponding changes in classification and treatment concepts. Moreover, tumor biology has become better integrated with clinical neuro-oncology in truly translational efforts. These advances receive detailed attention. In addition, the structure of the book has been adapted to align with the revised 2016 version of the WHO Brain Tumor Classification. Once again, the contributors have been carefully selected as leading experts in the field. Oncology of CNS Tumors is already established as a widely used reference, and this new edition will provide optimal value for highly specialized comprehensive neuro-oncology centers as well as practicing clinicians and researchers.